Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38341
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorBITO, Virginie
dc.contributor.authorJager, Manon Marie
dc.date.accessioned2022-09-26T08:19:41Z-
dc.date.available2022-09-26T08:19:41Z-
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/1942/38341-
dc.format.mimetypeApplication/pdf
dc.languageen
dc.publishertUL
dc.titleUsing pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy
dc.typeTheses and Dissertations
local.bibliographicCitation.jcatT2
dc.description.notesMaster of Biomedical Sciences-Molecular Mechanisms in Health and Disease
local.type.specifiedMaster thesis
item.fulltextWith Fulltext-
item.fullcitationJager, Manon Marie (2022) Using pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy.-
item.contributorJager, Manon Marie-
item.accessRightsOpen Access-
Appears in Collections:Master theses
Files in This Item:
File Description SizeFormat 
51293e0d-82f6-468c-9860-1e22f12597f7.pdf1.62 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.